Together with the evidence showing that over-activation of SLC11A1 could potentially induce and maintain autoimmune diseases, these data make SLC11A1 a candidate gene for autoimmune and immune-mediated disorders, such as T1D. This evidence concerns the gene SLC11A1 and type 1 diabetes mellitus.